Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Unitary patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2010 069 491.7 |
| 96 | EP file number | EAKZ | 22 20 0670.2 |
| 97 | EP publication number | EPN | 4183412 |
| 54 | Designation/title | TI | RSV-F-PROTEINZUSAMMENSETZUNGEN UND VERFAHREN ZU IHRER HERSTELLUNG |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/155 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C07K 14/135 (2006.01), C07K 16/10 (2006.01) |
| 22 | DE application date | DAT | Jul 15, 2010 |
| 96 | EP application date | EAT | Jul 15, 2010 |
| 43 | Date of first publication | OT | May 24, 2023 |
| Date of publication of grant | PET | Aug 14, 2024 |
| 71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals SA, 1330 Rixensart, BE |
| 72 | Inventor | IN | SWANSON, Kurt, Emeryville, CA 94662-8097, US; DORMITZER, Philip, R., Emeryville, CA 94662-8097, US |
| 74 | Representative | VTR | J A Kemp LLP, London EC1M 5QU, GB |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
22580509 P
Jul 15, 2009
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
29442610 P
Jan 12, 2010
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Member states EPGÜ | EPGUE | AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, SE, SI |
| Published EP/WO documents | EPWOPN | Original document:
EP000004183412A1
Searchable text:
EP000004183412A1
Original document:
EP000004183412B1
Searchable text:
EP000004183412B1 |
| 43 | Date of first publication | EVT | May 24, 2023 |
| Date of the first transfer into DPMAregister | EREGT | May 24, 2023 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 7, 2025
(Show all update days)(Hide all update days)- Aug 7, 2025
- Procedures: Procedure relating to EP application, Grant has become final, 15.05.2025: changed
- Jul 10, 2025
- St.36: changed (technical change)
- Jul 3, 2025
- Procedures: Procedure relating to EP application, Grant has become final, 15.05.2025: new
- May 15, 2025
- St.36: changed (technical change)
- May 1, 2025
- Type of IP right: changed
- File number displayed in the result list: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.08.2024: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.08.2024: deleted
- Mar 27, 2025
- Procedures: EP procedure, EP patent - unitary effect registered, 22.08.2024: changed
- Procedures: EP procedure, EP patent - unitary effect effective, 14.08.2024: changed
- Feb 20, 2025
- Applicant/owner: changed
- Representative: new
- Address for service: deleted
- Due date: deleted
- Member states EPGÜ: new
- Procedures: EP procedure, EP patent - unitary effect effective, 14.08.2024: new
- Procedures: EP procedure, EP patent - unitary effect registered, 22.08.2024: new
- Procedures: Nullity procedure, Action brought for declaration of nullity, 05.08.2024: new
- Aug 29, 2024
- Procedures: EP procedure, EP patent - request for unitary effect, 14.08.2024: new
- Aug 9, 2024
- Procedures: Publications, DPMA mention of EP grant, 05.09.2024: new
- Jul 30, 2024
- Applicant/owner: new
- Address for service: new
- Due date: new
- Jul 25, 2024
- DE file number : new
- DE application date: new
- Date of publication of grant: new
- Published EP/WO documents: changed
- File number displayed in the result list: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.08.2024: new
- May 2, 2024
- Historical data not available for this/these date(s)
- May 24, 2023
- Date of the first transfer into DPMAregister
|
